Genetic ablation of TRESK did not alter expression of TREK-1 or TREK-2, two other K2P channels recently implicated in migraine pathogenesis (Royal et al., 2019) (Supplementary Fig. 9). The gene discussed is KCNK2; the disease is migraine disorder.